Article | August 16, 2017

Could A Fear Of QbD Slow Your Breakthrough Therapy Drug's Speed To Market?

Source: Piramal Pharma Solutions

By V. Ammoscato, MSC, et al

scientist analyzing test tube of medicine in laboratory

As pharma continues to evolve, the drive to pursue new cutting-edge drugs will become even greater. For those companies competing to push the boundaries of innovation, a fear of implementing QbD might end up being the biggest threat in its race to the finish.